Balance Sheet

Assets

-73%

-78%

10Y

Currency: KRW

	Dec-2001	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	3 246	11 209	4 102	3 803	7 551	4 564	2 408	1 252	1 543	5 394	3 335	4 531	3 923	3 347	3 551	7 059	9 239	31 746	22 722	12 380	21 752	5 024	10 607	3 864
Cash	0	0	0	0	0	0	0	0	0	0	0	0	2	3	4	0	0	0	0	0	0	0	0	0
Cash Equivalents	3 246	11 209	4 102	3 803	7 551	4 564	2 408	1 252	1 543	5 394	3 335	4 531	3 921	3 344	3 547	7 059	9 239	31 746	22 722	12 380	21 752	5 024	10 607	3 864
Short-Term Investments	236	3 052	4 665	3 265	10 514	6 329	11 518	3 539	3 147	17	447	360	50	0	0	6 075	573	0	5 000	0	1 000	500	80	0
Total Receivables	2 295	3 435	4 271	4 098	4 125	3 077	5 763	15 870	12 274	18 513	15 106	13 058	9 730	8 277	8 213	5 683	5 953	12 591	5 598	10 630	11 182	11 143	1 104	1 039
Accounts Receivables	2 278	3 404	3 460	3 168	4 076	2 907	5 762	13 903	10 111	12 899	10 935	9 348	7 921	5 828	4 940	3 726	5 920	8 034	4 352	10 231	10 370	9 214	1 017	664
Other Receivables	17	31	811	930	49	170	1	1 967	2 163	5 614	4 171	3 710	1 809	2 449	3 273	1 957	33	4 557	1 246	399	813	1 928	87	374
Inventory	1 896	1 963	2 377	2 825	2 350	2 571	2 638	10 968	7 021	8 515	10 079	12 800	5 231	7 502	7 478	8 001	6 672	9 219	6 497	11 209	7 765	14 754	1 893	1 633
Other Current Assets	194	272	413	71	315	510	963	2 522	3 681	4 566	4 032	2 126	2 829	2 852	2 233	3 255	1 559	3 734	460	2 237	602	1 191	3 231	402
Total Current Assets	7 867	19 930	15 829	14 062	24 856	17 051	23 289	34 152	27 665	37 005	32 999	32 874	21 763	21 978	21 475	30 073	23 995	57 289	40 277	36 456	42 301	32 612	16 915	6 937
PP&E Net	3 250	4 281	6 494	7 995	7 918	15 423	14 060	30 936	19 071	20 999	26 630	26 158	24 885	23 628	24 208	27 738	29 653	28 662	30 123	48 512	42 899	42 339	2 878	4 129
PP&E Gross	3 250	4 281	6 494	7 995	7 918	15 423	14 060	30 936	19 071	20 999	26 630	26 158	24 885	23 628	24 208	27 738	0	28 662	30 123	48 512	42 899	42 339	2 878	4 129
Accumulated Depreciation	668	1 090	1 599	2 409	3 341	4 329	6 203	5 799	6 641	6 269	7 599	8 934	10 740	12 188	13 475	14 838	0	13 559	2 953	6 134	8 168	10 455	2 537	2 753
Intangible Assets	88	61	2 047	2 084	2 121	1 020	344	2 633	2 611	1 168	1 558	1 543	2 056	1 851	1 599	1 413	6 264	763	334	1 480	1 542	1 170	549	221
Goodwill	0	0	0	0	0	0	0	6 558	5 101	5 101	5 101	5 101	5 446	5 446	5 101	5 101	0	5 101	5 997	29 389	13 151	8 000	0	0
Note Receivable	0	0	0	300	300	300	276	294	0	0	0	0	0	275	293	302	0	0	395	347	0	0	1 787	2 171
Long-Term Investments	1 076	1 113	1 175	935	1 017	1 175	1 820	7 552	5 651	7 462	5 341	3 357	9 567	10 494	7 262	4 104	4 973	7 528	7 500	15 881	26 649	17 221	22 266	14 094
Other Long-Term Assets	372	646	794	696	1 515	3 536	3 902	4 504	3 253	3 496	3 484	2 187	1 710	2 097	3 258	4 656	3 359	4 540	4 487	2 261	3 799	2 345	407	8 905
Other Assets	0	0	0	0	0	0	0	6 558	5 101	5 101	5 101	5 101	5 446	5 446	5 101	5 101	0	5 101	5 997	29 389	13 151	8 000	0	0
Total Assets	12 653 N/A	26 032 +106%	26 339 +1%	26 072 -1%	37 726 +45%	38 505 +2%	43 691 +13%	86 629 +98%	63 353 -27%	75 231 +19%	75 112 0%	71 220 -5%	65 427 -8%	65 770 +1%	63 196 -4%	73 386 +16%	68 245 -7%	103 883 +52%	89 113 -14%	134 325 +51%	130 341 -3%	103 687 -20%	44 802 -57%	36 458 -19%
Liabilities
Accounts Payable	3 338	3 524	3 133	2 833	2 482	2 595	6 147	9 943	3 659	5 126	2 717	1 643	3 137	2 593	3 309	3 155	8 534	1 790	1 334	5 490	7 254	2 845	1 078	403
Accrued Liabilities	6	6	9	18	22	81	83	317	243	726	1 017	270	73	239	126	168	0	373	339	571	447	556	63	54
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	19 139	18 903	3 692	2 813	1 184	10 650	3 591	2 940	2 940	14 328	0	1 000
Current Portion of Long-Term Debt	380	295	395	29	0	150	300	31 677	24 060	25 925	25 351	29 069	4 248	375	249	2 749	26 747	11 635	5 345	15 700	18 104	17 235	1 771	3 265
Other Current Liabilities	1 110	1 422	844	487	1 137	1 977	1 711	3 809	2 990	4 342	4 383	3 022	5 445	4 546	6 348	10 058	1 081	5 726	6 048	7 030	8 255	14 015	5 054	1 907
Total Current Liabilities	4 834	5 247	4 381	3 366	3 641	4 802	8 242	45 746	30 951	36 119	33 468	34 004	32 042	26 656	13 724	18 942	37 546	30 174	16 658	31 731	37 000	48 979	7 965	6 629
Long-Term Debt	536	428	33	0	0	1 050	750	11 842	6 565	3 247	4 368	1 014	1 457	957	15 176	23 381	516	0	19 763	25 307	20 851	11 143	2 491	1 835
Deferred Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	412	360	310	252	203
Minority Interest	0	0	0	0	0	0	0	8 175	8 498	8 571	8 357	8 168	2 491	5 359	4 787	4 985	7 566	11 697	5 444	6 815	7 013	7 282	380	22
Other Liabilities	103	193	328	571	881	1 117	1 441	1 373	290	320	510	679	1 059	1 549	1 646	2 029	2 430	2 095	1 796	3 958	6 622	2 172	2 295	3 524
Total Liabilities	5 472 N/A	5 868 +7%	4 742 -19%	3 937 -17%	4 522 +15%	6 969 +54%	10 432 +50%	67 136 +544%	46 303 -31%	48 258 +4%	46 703 -3%	43 865 -6%	37 049 -16%	34 521 -7%	35 334 +2%	49 336 +40%	48 058 -3%	43 966 -9%	43 661 -1%	68 224 +56%	71 845 +5%	69 886 -3%	13 383 -81%	12 211 -9%
Equity
Common Stock	2 000	2 860	3 028	3 028	4 353	4 353	4 353	4 353	5 933	11 006	12 956	13 624	15 019	17 233	18 992	19 871	19 871	30 794	30 953	43 498	44 485	44 485	44 485	4 449
Retained Earnings	3 804	8 834	9 766	10 370	11 162	11 576	11 283	5 300	13 181	12 036	11 915	14 609	17 817	18 997	25 420	30 479	33 458	32 255	44 046	62 070	82 200	95 790	102 983	68 625
Additional Paid In Capital	1 377	8 470	8 772	8 772	17 624	17 624	17 585	17 624	22 841	25 058	27 681	29 071	30 404	31 388	33 949	35 091	35 216	64 582	64 365	93 067	100 007	99 995	101 175	102 524
Unrealized Security Profit/Loss	0	0	30	36	92	214	38	3 584	2 223	3 714	488	106	850	1 722	425	531	0	3 141	5 308	7 899	3 349	14 474	10 861	13 769
Treasury Stock	0	0	0	0	26	2 231	0	0	0	1	1	1	1	1	1	1	1	1	1	1	2	2	2	2
Other Equity	0	0	0	0	0	0	0	767	767	767	800	835	76	95	82	100	1 440	61	510	493	445	414	396	330
Total Equity	7 181 N/A	20 164 +181%	21 596 +7%	22 135 +2%	33 204 +50%	31 536 -5%	33 259 +5%	19 493 -41%	17 049 -13%	26 973 +58%	28 409 +5%	27 355 -4%	28 379 +4%	31 249 +10%	27 862 -11%	24 051 -14%	20 187 -16%	59 917 +197%	45 453 -24%	66 102 +45%	58 497 -12%	33 800 -42%	31 419 -7%	24 247 -23%
Total Liabilities & Equity	12 653 N/A	26 032 +106%	26 339 +1%	26 072 -1%	37 726 +45%	38 505 +2%	43 691 +13%	86 629 +98%	63 353 -27%	75 231 +19%	75 112 0%	71 220 -5%	65 427 -8%	65 770 +1%	63 196 -4%	73 386 +16%	68 245 -7%	103 883 +52%	89 113 -14%	134 325 +51%	130 341 -3%	103 687 -20%	44 802 -57%	36 458 -19%
Shares Outstanding
Common Shares Outstanding	2	3	3	3	3	3	3	3	4	7	8	8	9	10	11	12	12	18	19	26	27	27	27	27

Income Statement Balance Sheet Cash Flow Statement

BL PharmTech Corp
KOSDAQ:065170

Balance Sheet

Balance Sheet Decomposition
BL PharmTech Corp

Balance Sheet
BL PharmTech Corp

See Also

Company

Help

Tools

Stocks

BL PharmTech Corp KOSDAQ:065170

Balance Sheet

Balance Sheet Decomposition BL PharmTech Corp

Balance Sheet BL PharmTech Corp

See Also

Company

Help

Tools

Stocks

BL PharmTech Corp
KOSDAQ:065170

Balance Sheet Decomposition
BL PharmTech Corp

Balance Sheet
BL PharmTech Corp